Finance

Lists
Why is 600594 up 2.51%?
Dive Deeper
600594:SHA
GuiZhou YiBai Pharmaceutical Co., Ltd.
CNÂ¥3.68
+2.51%
(+0.090) 1D
Oct 9, 3:00:02 PM GMT+8  ·   CNY
All symbols
SymbolPriceChange% Change
Generating top insights for 600594...
Open
CNÂ¥3.58
High
CNÂ¥3.69
Low
CNÂ¥3.52
Mkt. cap
2.86B
Avg. vol.
41.16M
Volume
23.17M
52-wk high
CNÂ¥5.27
52-wk low
CNÂ¥2.85
EPS
-CNÂ¥0.49
Shares outstanding
791.93M
No. of employees
5K
Open
CNÂ¥3.58
High
CNÂ¥3.69
Low
CNÂ¥3.52
Mkt. cap
2.86B
Avg. vol.
41.16M
Volume
23.17M
52-wk high
CNÂ¥5.27
52-wk low
CNÂ¥2.85
EPS
-CNÂ¥0.49
Shares outstanding
791.93M
No. of employees
5K
News stories
From web sources and news partners
About GuiZhou YiBai Pharmaceutical Co., Ltd.
CEO-
Employees4.83K
FoundedJun 12, 1995
Headquarters-
SectorPharmaceutical industry
Websitegzcci.com
Previous reportsAll values in CNY
Loading Previous Earnings...
Revenue
Net income
All values in CNY
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Revenue
453.58M
416.22M
358.84M
330.55M
Cost of goods sold
165.60M
205.61M
150.99M
171.44M
Cost of revenue
165.60M
205.61M
150.99M
171.44M
Research and development expenses
25.31M
21.85M
13.47M
18.05M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
276.16M
283.81M
196.25M
197.70M
Operating expense
292.28M
328.94M
213.94M
224.89M
Total operating expenses
457.88M
534.55M
364.93M
396.33M
Operating income
-4.30M
-118.33M
-6.09M
-65.78M
Other non operating income
-1.51M
-122.19K
-228.77K
-301.40K
EBT including unusual items
-69.17M
-218.73M
-20.88M
-52.20M
EBT excluding unusual items
-11.96M
-123.43M
-11.52M
-71.19M
Income tax expense
-898.39K
25.98M
8.09M
-2.70M
Effective tax rate
1.30%
-11.88%
-38.74%
5.17%
Other operating expenses
-9.81M
23.29M
4.27M
9.51M
Net income
-66.66M
-243.00M
-29.52M
-50.81M
Net profit margin
-14.70%
-58.38%
-8.23%
-15.37%
Earnings per share
-
-
-
-
Interest and investment income
1.13M
979.10K
485.26K
583.10K
Interest expense
-7.28M
-5.96M
-5.69M
-5.69M
Net interest expenses
-6.15M
-4.98M
-5.21M
-5.11M
Depreciation and amortization charges
-
-
-
-
EBITDA
41.68M
-77.35M
34.89M
-28.17M
Gain or loss from assets sale
17.43K
27.21M
-
-1.83M
AI content may include mistakes. Learn more
Google apps